Cell Signaling Technology

SimpleChIP® Rat CCRN4L Promoter Primers

#7983 · $137

100
Citing papers
5.1k
Combined citations
Supplier page Find this product

Research areas

Nerve injury and regeneration11Epigenetics and DNA Methylation10NF-κB Signaling Pathways6Neuroscience and Neuropharmacology Research5Cancer-related gene regulation5Cell death mechanisms and regulation5Immune Response and Inflammation5Neurogenesis and neuroplasticity mechanisms5

Papers citing this product

1
Mammalian TAK1 Activates Snf1 Protein Kinase in Yeast and Phosphorylates AMP-activated Protein Kinase in Vitro
Journal of Biological Chemistry·2006·461 cit.·DOI
2
IRE1α–XBP1 controls T cell function in ovarian cancer by regulating mitochondrial activity
Nature·2018·402 cit.·DOI
3
Activation of the Trk Signaling Pathway by Extracellular Zinc
Journal of Biological Chemistry·2005·204 cit.·DOI
4
<p>Exosomes Derived from Bone Mesenchymal Stem Cells with the Stimulation of Fe<sub>3</sub>O<sub>4</sub> Nanoparticles and Static Magnetic Field Enhance Wound Healing Through Upregulated miR-21-5p</p>
International Journal of Nanomedicine·2020·198 cit.·DOI
5
Neuron and microglia/macrophage-derived FGF10 activate neuronal FGFR2/PI3K/Akt signaling and inhibit microglia/macrophages TLR4/NF-κB-dependent neuroinflammation to improve functional recovery after spinal cord injury
Cell Death and Disease·2017·180 cit.·DOI
6
The BDNF effects on dendritic spines of mature hippocampal neurons depend on neuronal activity
Frontiers in Synaptic Neuroscience·2014·170 cit.·DOI
7
Human Adipose Tissue-Derived Stromal/Stem Cells Promote Migration and Early Metastasis of Triple Negative Breast Cancer Xenografts
PLoS ONE·2014·169 cit.·DOI
8
ERK3 signals through SRC-3 coactivator to promote human lung cancer cell invasion
Journal of Clinical Investigation·2012·168 cit.·DOI
9
Mitochondrial Translocation of p53 Mediates Release of Cytochrome <i>c</i> and Hippocampal CA1 Neuronal Death after Transient Global Cerebral Ischemia in Rats
Journal of Neuroscience·2006·161 cit.·DOI
10
Loss of AIM2 expression promotes hepatocarcinoma progression through activation of mTOR-S6K1 pathway
Oncotarget·2016·130 cit.·DOI